Nxera Pharma Co.,Ltd. [4565.T]
TOKYO, Apr 15 (Pulse News Wire) – Nxera Pharma CO.,LTD. (4565.T) announced today that it will issue new ordinary shares worth ¥1,000 per share for its Employee Stock Ownership Plan (ESOP) and Restricted Stock Unit (RSU) programs.
Under the ESOP program, the company plans to issue approximately ¥2.5 million new shares to be allocated to Nippon Custodian Bank Trust E Account by April 30, 2026. This issuance is aimed at ensuring sufficient shares for transitioning existing RSUs to the ESOP plan without additional dilution beyond previously anticipated levels. Additionally, the company decided on the issuance price and allocation of new shares based on RSU programs from the 26th to the 28th cycles.
The 26th cycle will involve issuing 2.3 million shares to six executives and three senior executives, while the 27th and 28th cycles will allocate shares to 68 employees and advisors, contingent upon their continued employment until certain dates ranging from April 1, 2026, to July 31, 2029. Furthermore, the company also determined the issuance prices and allocations for previous RSU cycles, such as the 18th and 20th cycles, which will result in the issuance of 1.4 million shares to 147 individuals by May 18, 2026. These issuances aim to align employee interests with shareholder value through stock-based compensation mechanisms, promoting long-term growth and performance alignment within the organization.
🟡 Confidence: Standard AI-translated content.